Jaguar Global Growth Corp I - Quarter Report: 2022 September (Form 10-Q)
Table of Contents
☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Cayman Islands |
001-41284 |
98-1593783 | ||
(State or other jurisdiction of incorporation or organization) |
(Commission File Number) |
(IRS Employer Identification No.) | ||
601 Brickell Key Drive, Suite 700 Miami, Florida |
33131 | |||
(Address of principal executive offices) |
(Zip Code) |
Title of Each Class |
Trading Symbols |
Name of Each Exchange on Which Registered | ||
Units, each consisting of one Class A ordinary share, one right and one-half of one redeemable warrant |
JGGCU |
The Nasdaq Stock Market LLC | ||
Class A ordinary shares, par value $0.0001 per share |
JGGC |
The Nasdaq Stock Market LLC | ||
Rights entitling the holder thereof to receive one-twelfth (1/12) of one Class A ordinary share of the Company |
JGGCR |
The Nasdaq Stock Market LLC | ||
Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 |
JGGCW |
The Nasdaq Stock Market LLC |
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer |
☒ | Smaller reporting company | ☒ | |||
Emerging growth company | ☒ |
Table of Contents
Jaguar Global Growth Corporation I
Form 10-Q
For the Quarter Ended September 30, 2022
Table of Contents
i
Table of Contents
Item 1. |
Condensed Financial Statements |
September 30, 2022 (Unaudited) |
December 31, 2021 |
|||||||
ASSETS |
||||||||
Cash |
$ | 762,101 | $ | 33,640 | ||||
Prepaid expenses |
626,805 | 3,070 | ||||||
Total current assets |
1,388,906 | 36,710 | ||||||
Deferred offering costs |
— | 396,046 | ||||||
Marketable securities held in Trust Account |
236,061,403 | — | ||||||
Other non-current assets |
211,771 | — | ||||||
Total Assets |
$ |
237,662,080 |
$ |
432,756 |
||||
LIABILITIES, ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND SHAREHOLDERS’ DEFICIT |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | 5,019 | $ | 26,780 | ||||
Due to related party |
30,873 | 3,893 | ||||||
Note payable |
— | 250,000 | ||||||
Accrued expenses |
— | 167,037 | ||||||
Total current liabilities |
35,892 | 447,710 | ||||||
Deferred underwriting fees payable |
8,050,000 | — | ||||||
Derivative warrant liabilities |
1,437,000 | — | ||||||
Total liabilities |
9,522,892 | 447,710 | ||||||
Commitments and Contingencies (Note 6) |
||||||||
Class A ordinary shares subject to possible redemption, $0.0001 par value; 23,000,000 shares at redemption value of $10.26 per share |
235,961,403 | — | ||||||
Shareholders’ deficit |
||||||||
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding |
— | — | ||||||
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; none issued or outstanding (excluding 23,000,000 shares subject to possible redemption) |
— | — | ||||||
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 7,666,667 shares issued and outstanding |
767 | 767 | ||||||
Additional paid-in capital |
— | 24,233 | ||||||
Accumulated deficit |
(7,822,982 | ) | (39,954 | ) | ||||
Total shareholders’ deficit |
(7,822,215 | ) | (14,954 | ) | ||||
Total Liabilities, Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit |
$ |
237,662,080 |
$ |
432,756 |
||||
For the Three Months Ended September 30, 2022 |
For the Three Months Ended September 30, 2021 |
For the Nine Months Ended September 30, 2022 |
For the Period From March 31, 2021 (Inception) Through September 30, 2021 |
|||||||||||||
Formation costs |
$ | — | $ | — | $ | — | $ | 33,333 | ||||||||
General and administrative expenses |
315,856 | 22 | 886,390 | 2,236 | ||||||||||||
Loss from operations |
(315,856 | ) | (22 | ) | (886,390 | ) | (35,569 | ) | ||||||||
Change in fair value of derivative warrant liabilities |
2,155,500 | — | 4,851,300 | — | ||||||||||||
Gain on marketable securities (net), dividends and interest, held in Trust Account |
1,101,799 | — | 1,461,403 | — | ||||||||||||
Transaction costs allocation to derivative warrant liabilities |
— | — | (215,039 | ) | — | |||||||||||
Net income (loss) |
$ | 2,941,443 | $ | (22 | ) | $ | 5,211,274 | $ | (35,569 | ) | ||||||
Weighted average shares outstanding of Class A ordinary shares subject to possible redemption, basic and diluted |
23,000,000 | — | 19,208,791 | — | ||||||||||||
Basic and diluted income per share, Class A subject to possible redemption |
$ |
0.10 |
$ |
— | $ |
0.20 |
$ |
— | ||||||||
Weighted average shares outstanding of Class B ordinary shares, basic and diluted |
7,666,667 | 6,666,667 | 7,501,832 | 6,666,667 | ||||||||||||
Basic and diluted income (loss) per share, Class B ordinary shares |
$ |
0.10 |
$ |
(0.00 |
) |
$ |
0.20 |
$ |
(0.01 |
) | ||||||
Ordinary Shares |
||||||||||||||||||||
Class B |
||||||||||||||||||||
Shares |
Amount |
Additional Paid-In Capital |
Accumulated Deficit |
Total Shareholders’ Deficit |
||||||||||||||||
Balance as of January 1, 2022 |
7,666,667 | $ | 767 | $ | 24,233 | $ | (39,954 | ) | $ | (14,954 | ) | |||||||||
Fair value of rights |
— | — | 1,410,946 | — | 1,410,946 | |||||||||||||||
Other offering costs |
— | — | (82,164 | ) | — | (82,164 | ) | |||||||||||||
Excess cash received over fair value of Private Placement Warrants |
— | — | 9,163,200 | — | 9,163,200 | |||||||||||||||
Accretion of Class A ordinary shares to redemption value |
— | — | (10,516,215 | ) | (11,632,899 | ) | (22,149,114 | ) | ||||||||||||
Net loss |
— | — | — | (1,389,109 | ) | (1,389,109 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance as of March 31, 2022 (unaudited) |
7,666,667 |
767 |
— |
(13,061,962 |
) |
(13,061,195 |
) | |||||||||||||
Accretion of Class A ordinary shares to redemption value |
— | — | — | (259,604 | ) | (259,604 | ) | |||||||||||||
Net income |
— | — | — | 3,658,940 | 3,658,940 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance as of June 30, 2022 (unaudited) |
7,666,667 |
767 |
— |
(9,662,626 |
) |
(9,661,859 |
) | |||||||||||||
Accretion of Class A ordinary shares to redemption value |
— | — | — | (1,101,799 | ) | (1,101,799 | ) | |||||||||||||
Net income |
— | — | — | 2,941,443 | 2,941,443 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance as of September 30, 2022 (unaudited) |
7,666,667 |
$ |
767 |
$ |
— |
$ |
(7,822,982 |
) |
$ |
(7,822,215 |
) | |||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Ordinary Shares |
||||||||||||||||||||
Class B |
||||||||||||||||||||
Shares |
Amount |
Additional Paid-In Capital |
Accumulated Deficit |
Total Shareholders’ Deficit |
||||||||||||||||
Balance as of March 31, 2021 (inception) |
— | $ | — | $ | — | $ | — | $ | — | |||||||||||
Issuance of ordinary shares to Sponsor |
7,666,667 | 767 | 24,233 | — | 25,000 | |||||||||||||||
Net loss |
— | — | — | (35,547 | ) | (35,547 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance as of June 30, 2021 (unaudited) |
7,666,667 | 767 | 24,233 | (35,547 | ) | (10,547 | ) | |||||||||||||
Net loss |
— | — | — | (22 | ) | (22 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance as of September 30, 2021 (unaudited) |
7,666,667 |
$ |
767 |
$ |
24,233 |
$ |
(35,569 |
) |
$ |
(10,569 |
) | |||||||||
|
|
|
|
|
|
|
|
|
|
For the Nine Months Ended September 30, 2022 |
For the Period From March 31, 2021 (Inception) Through September 30, 2021 |
|||||||
Cash Flows from Operating Activities |
||||||||
Net income (loss) |
$ | 5,211,274 | $ | (35,569 | ) | |||
Adjustments to reconcile net income (loss) to net cash used in operating activities: |
||||||||
Gain on marketable securities (net), dividends and interest, held in Trust Account |
(1,461,403 | ) | — | |||||
Transaction costs allocated to derivative warrant liabilities |
215,039 | — | ||||||
Formation and operating expenses funded by related party |
30,873 | — | ||||||
Change in fair value of derivative warrant liabilities |
(4,851,300 | ) | — | |||||
Changes in operating assets and liabilities: |
||||||||
Prepaid and other assets |
(835,506 | ) | — | |||||
Accounts payable |
5,019 | — | ||||||
Accrued expenses |
(428 | ) | 25,000 | |||||
|
|
|
|
|||||
Net cash used in operating activities |
(1,686,432 | ) | (10,569 | ) | ||||
|
|
|
|
|||||
Cash Flows from Investing Activities |
||||||||
Investment of cash into Trust Account |
(234,600,000 | ) | — | |||||
|
|
|
|
|||||
Net cash used in investing activities |
(234,600,000 | ) | — | |||||
|
|
|
|
|||||
Cash Flows from Financing Activities |
||||||||
Proceeds from issuance of ordinary shares to Sponsor |
— | 25,000 | ||||||
Proceeds from note payable and advances from related party |
— | 150,000 | ||||||
Repayment of note payable and advances from related party |
(253,893 | ) | — | |||||
Proceeds from sale of Class A shares, gross |
230,000,000 | — | ||||||
Proceeds from sale of Private Placement Warrants |
12,450,000 | — | ||||||
Offering costs paid |
(5,181,214 | ) | (111,092 | ) | ||||
|
|
|
|
|||||
Net cash provided by financing activities |
237,014,893 | 63,908 | ||||||
|
|
|
|
|||||
Net change in cash |
728,461 | 53,339 | ||||||
Cash—beginning of period |
33,640 | — | ||||||
|
|
|
|
|||||
Cash—end of period |
$ | 762,101 | $ | 53,339 | ||||
|
|
|
|
|||||
Supplemental disclosure of noncash investing and financing activities: |
||||||||
Offering costs included in accounts payable |
$ | — | $ | 92,552 | ||||
|
|
|
|
|||||
Offering costs included in accrued expenses |
$ | — | $ | 113,205 | ||||
|
|
|
|
|||||
Deferred underwriting fees payable |
$ | 8,050,000 | $ | — | ||||
|
|
|
|
Gross proceeds from sale of Class A ordinary shares |
$ | 230,000,000 | ||
Less: Class A ordinary shares issuance costs |
(13,136,668 | ) | ||
Less: Fair value of Public Warrants at issuance |
(3,001,500 | ) | ||
Less: Fair value of rights |
(1,410,946 | ) | ||
Plus: Accretion of carrying value to redemption value |
22,149,114 | |||
Class A ordinary shares subject to possible redemption at March 31, 2022 |
234,600,000 |
|||
Plus: Accretion of carrying value to redemption value |
259,604 | |||
Class A ordinary shares subject to possible redemption at June 30, 2022 |
234,859,604 |
|||
Plus: Accretion of carrying value to redemption value |
1,101,799 | |||
Class A ordinary shares subject to possible redemption at September 30, 2022 |
$ |
235,961,403 |
||
For the Three Months Ended September 30, 2022 |
For the Three Months Ended September 30, 2021 |
For the Nine Months Ended September 30, 2022 |
For the Period From March 31, 2021 (Inception) Through September 30, 2021 |
|||||||||||||
Redeemable Class A Ordinary Shares |
||||||||||||||||
Numerator: Net income allocable to Redeemable Class A Ordinary Shares |
$ | 2,206,082 | $ | — | $ | 3,747,658 | $ | — | ||||||||
Denominator: Weighted Average Share Outstanding, Redeemable Class A Ordinary Shares |
23,000,000 | — | 19,208,791 | — | ||||||||||||
Basic and diluted net income per share, Class A subject to possible redemption |
$ | 0.10 | $ | — |
$ | 0.20 | $ | |||||||||
Class B Ordinary Shares |
||||||||||||||||
Numerator: Net income (loss) allocable to non-redeemable Class B Ordinary Shares |
$ | 735,361 | $ | (22 | ) | $ | 1,463,616 | $ | (35,569 | ) | ||||||
Denominator: Weighted Class B Ordinary Shares |
7,666,667 | 6,666,667 | 7,501,832 | 6,666,667 | ||||||||||||
Basic and diluted net income ( per share, Class B ordinary sharesloss ) |
$ | 0.10 | $ | (0.00 | ) |
$ | 0.20 | $ | (0.01 | ) | ||||||
• | in whole and not in part; |
• | at a price of $0.01 per warrant; |
• | upon a minimum of 30 days’ prior written notice of redemption; and |
• | if, and only if the last reported sale price of Class A Ordinary Shares for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders (the “Reference Value”) equals or exceeds $18.00 per share (as adjusted). |
• | in whole and not in part; |
• | at a price of $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption, provided that holders will be able to exercise their warrants on a cashless basis after receiving notice of redemption but prior to redemption and receive that number of Class A Ordinary Shares to be determined by reference to an agreed table based on the redemption date and the “fair market value” of Class A Ordinary Shares; |
• | if, and only if the Reference Value equals or exceeds $10.00 per share (as adjusted); and |
• | if, and only if the Reference Value is less than $18.00 per share (as adjusted), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants. The fair market value” of Class A Ordinary Shares shall mean the volume-weighted average price of Class A Ordinary Shares for the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.361 Class A Ordinary Shares per warrant (subject to adjustment). |
Level 1 |
Level 2 |
Level 3 |
Total |
|||||||||||||
Assets: |
||||||||||||||||
Marketable securities held in Trust Account |
$ | 236,061,403 | $ | — | $ | — | $ | 236,061,403 | ||||||||
Total assets |
$ | 236,061,403 | $ | — | $ | — | $ | 236,061,403 | ||||||||
Liabilities: |
||||||||||||||||
Public Warrants |
$ | — | $ | 690,000 | $ | — | $ | 690,000 | ||||||||
Private Placement Warrants |
— | 747,000 | — | 747,000 | ||||||||||||
Total liabilities |
$ | — | $ | 1,437,000 | $ | — | $ | 1,437,000 | ||||||||
Public Warrants |
Private Placement Warrants |
Total |
||||||||||
Fair value as of February 15, 2022 |
$ | 3,001,500 | $ | 3,286,800 | $ | 6,288,300 | ||||||
Change in fair value |
414,000 | 522,900 | 936,900 | |||||||||
Fair value as of March 31, 2022 |
3,415,500 | 3,809,700 | 7,225,200 | |||||||||
Change in fair value |
(1,690,500 | ) | (1,942,200 | ) | (3,632,700 | ) | ||||||
Fair value as of June 30, 2022 |
1,725,000 | 1,867,500 | 3,592,500 | |||||||||
Change in fair value |
(1,035,000 | ) | (1,120,500 | ) | (2,155,500 | ) | ||||||
Fair value as of September 30, 2022 |
$ |
690,000 |
$ |
747,000 |
$ |
1,437,000 |
||||||
Public Warrants |
Private Placement Warrants |
Total |
||||||||||
Fair value as of February 15, 2022 |
$ | 3,001,500 | $ | 3,286,800 | $ | 6,288,300 | ||||||
Change in fair value |
414,000 | 522,900 | 936,900 | |||||||||
Fair value as of March 31, 2022 |
3,415,500 | 3,809,700 | 7,225,200 | |||||||||
Transfer to Level 2 |
(3,415,500 | ) | (3,809,700 | ) | (7,225,200 | ) | ||||||
Fair value as of June 30, 2022 |
$ |
— |
$ |
— |
$ |
— |
||||||
Fair value as of September 30, 2022 |
$ |
— |
$ |
— |
$ |
— |
||||||
Table of Contents
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations. |
References to the “company,” “our,” “us” or “we” refer to Jaguar Global Growth Corporation I. The following discussion and analysis of the company’s financial condition and results of operations should be read in conjunction with the unaudited interim condensed financial statements and the notes thereto contained elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.
Cautionary Note Regarding Forward-Looking Statements
This Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act. We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other SEC filings.
Overview
We are a blank check company incorporated on March 31, 2021 as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities.
Our sponsor is Jaguar Global Growth Partners I, LLC, a Delaware limited liability company. The registration statement for our initial public offering was declared effective on February 10, 2022. On February 15, 2022, we consummated the initial public offering of 23,000,000 units (“units” and, with respect to the Class A ordinary shares included in the units being offered, the “Class A Ordinary Shares”), at $10.00 per Unit, which includes the exercise in full of the underwriters’ option to purchase an additional 3,000,000 units at the initial public offering price to cover over-allotments, generating gross proceeds of $230.0 million, and incurring offering costs of approximately $12.65 million, inclusive of $8.05 million in deferred underwriting commissions. Each Unit consists of one Class A ordinary share, $0.0001 par value per share, one right to receive one-twelfth (1/12) of one Class A Ordinary Share and one-half of one redeemable warrant (“public warrants”), each whole public warrant entitling the holder thereof to purchase one Class A Ordinary Share at an exercise price of $11.50 per share, subject to adjustment.
Simultaneously with the closing of the initial public offering, we consummated the private placement (“private placement”) of 12,450,000 warrants at a price of $1.00 per warrant (“private placement warrants”) to the sponsor, generating gross proceeds of $12.45 million.
Upon the closing of the initial public offering and the private placement on February 15, 2022, $234.6 million ($10.20 per Unit) of the net proceeds of the sale of the units in the initial public offering and the private placement were placed in a non-interest bearing trust account (“trust account”) located in the United States with Continental Stock Transfer & Trust Company acting as trustee. Since the initial public offering, the proceeds have been and will only be invested in U.S. “government securities,” within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act, which invest only in direct U.S. government treasury obligations, as determined by the company, until the earlier of (i) the completion of a business combination and (ii) the distribution of the trust account as described below.
Our management has broad discretion with respect to the specific application of the net proceeds of our initial public offering and the sale of the private placement warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating our initial business combination.
If we have not completed our initial business combination within 18 months from the closing of the initial public offering, or August 15, 2023, we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account and not previously released to us to pay our taxes, if any (less up to $100,000 of interest to pay dissolution expenses and which interest shall be net of taxes payable), divided by the number of the then outstanding public shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and our board of directors, liquidate and dissolve, subject in each case to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.
18
Table of Contents
Liquidity and Capital Resources
As of September 30, 2022 we had cash of $762,101 outside of the trust account. We intend to use the funds held outside the trust account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel and structure, negotiate and complete an initial business combination.
19
Table of Contents
Prior to the completion of the initial public offering, our liquidity needs have been satisfied through (i) $25,000 paid by our initial shareholders to cover certain of our offering costs in exchange for the issuance of the founder shares to our initial shareholders and (ii) loan proceeds from our sponsor of an aggregate amount of $250,000 under an unsecured amended and restated promissory note, which we fully repaid upon the closing of the initial public offering. After the consummation of our initial public offering, our liquidity needs have been satisfied with the net proceeds from our initial public offering and the private placement.
We intend to use substantially all of the funds held in the trust account, including any amounts representing interest earned on the trust account, if any, (less taxes payable and deferred underwriting commissions), to complete our initial business combination. We may withdraw interest income (if any) to pay taxes, if any. Our annual tax obligations will depend on the amount of interest and other income earned on the amounts held in the trust account. We expect the interest income earned on the amount in the trust account (if any) will be sufficient to pay our taxes. To the extent that our equity or debt is used, in whole or in part, as consideration to complete our initial business combination, the remaining proceeds held in the trust account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.
Based on the foregoing, management believes that the company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a business combination or until the next periodic filing. Over this time period, the company will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial business combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the business combination.
We do not believe we will need to raise additional funds following the initial public offering in order to meet the expenditures required for operating our business prior to our initial business combination, other than funds available from loans from our sponsor, its affiliates or members of our management team. However, if our estimates of the costs of identifying a target business, undertaking in-depth due diligence and negotiating an initial business combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our initial business combination. In order to fund working capital deficiencies or finance transaction costs in connection with an intended initial business combination, our sponsor or an affiliate of our sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete our initial business combination, we may repay such loaned amounts out of the proceeds of the trust account released to us. In the event that our initial business combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our trust account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into warrants of the post-business combination entity at a price of $1.00 per warrant at the option of the lender. The warrants would be identical to the private placement warrants. The terms of such loans, if any, have not been determined and no written agreements exist with respect to such loans. Prior to the completion of our initial business combination, we do not expect to seek loans from parties other than our sponsor, its affiliates or our management team as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account.
We may need to obtain additional financing to complete our initial business combination, either because the transaction requires more cash than is available from the proceeds held in our trust account, or because we become obligated to redeem a significant number of our public shares upon completion of the business combination, in which case we may issue additional securities or incur debt in connection with such business combination. If we have not consummated our initial business combination within the required time period because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the trust account.
Going Concern
On a routine basis, we assess going concern considerations in accordance with FASB ASC 205-40 “Presentation of Financial Statements - Going Concern”. As of September 30, 2022 and December 31, 2021, we had $762,101 and $33,640, respectively, in our operating bank account, $1,353,014 and $411,000, respectively, of working capital and working capital deficiency and $236,061,403 of marketable securities held in the Trust Account as of September 30, 2022 to be used for a Business Combination or to repurchase or redeem our common stock in connection therewith. The Trust Account was established on February 15, 2022, and therefore did not have a balance as of the December 31, 2021 comparative date. The Sponsor intends, but is not obligated to, provide us with Working Capital Loans to sustain operations in the event of a liquidity deficiency.
We have until August 10, 2023, to consummate a Business Combination. If a Business Combination is not consummated by this date and an extension is not requested by the Sponsor there will be a mandatory liquidation and subsequent dissolution of the Company. The date for mandatory liquidation and subsequent dissolution within twelve months raises substantial doubt about our ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Management’s intent is to complete a Business Combination prior to the mandatory liquidation date.
20
Table of Contents
Results of Operations
Our entire activity from inception to September 30, 2022 was in preparation for our formation and the initial public offering, and since the initial public offering, our search for a prospective target for our initial business combination. We will not generate any operating revenues until after completion of our initial business combination, at the earliest. We may generate non-operating income in the form of interest income on cash and cash equivalents. There has been no significant change in our financial or trading position and no material adverse change has occurred since the date of our audited financial statements. Since the date of the initial public offering, we expect to incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.
For the three months ended September 30, 2022, we had net income of $2,941,443, consisting of a gain of $2,155,500 in change in fair value of derivative warrant liabilities, a gain of $1,101,799 related to marketable securities offset by $315,856 of general and administrative expenses.
For the three months ended September 30, 2021, we had a net loss of $22, consisting of $22 worth of general and administrative expenses.
For the nine months ended September 30, 2022, we had net income of $5,211,274, consisting of a gain of $4,851,300 in change in fair value of derivative warrant liabilities, a gain of $1,461,403 related to marketable securities, offset by $886,390 of general and administrative expenses, and $215,039 of transaction costs allocation to derivative warrant liabilities.
For the period from March 31, 2021 (inception) through September 30, 2021, we had a net loss of $35,569, consisting of $33,333 in formation costs and $2,236 in general and administrative expenses.
Contractual Obligations
Administrative Services Agreement
Commencing on February 10, 2022 we agreed to pay our sponsor or an affiliate of our sponsor a total of $10,000 per month for office space, secretarial and administrative services, research and other services provided to us and to reimburse our sponsor for any out-of-pocket expenses related to identifying, investigating and completing an initial business combination. Upon completion of the initial business combination or our liquidation, we will cease paying these monthly fees. For the three months and nine months ended September 30, 2022, the Company incurred and paid $30,000 and $80,000, respectively, for these services. As of September 30, 2022 and December 31, 2021, the Company had no balance outstanding for services in connection with such agreement on the accompanying condensed balance sheets.
Registration Rights
The holders of the founder shares, private placement warrants and any warrants that may be issued upon conversion of working capital loans (and any Class A ordinary shares issuable upon the exercise of the private placement warrants and warrants that may be issued upon conversion of working capital loans) are to registration rights pursuant to a registration and shareholder rights agreement to be signed prior to or on the effective date of this offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that we register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to our completion of our initial business combination. We will bear the expenses incurred in connection with the filing of any such registration statements.
Underwriting Agreement
We granted the underwriters a 45-day option from the final prospectus relating to the initial public offering to purchase up to 3,000,000 additional units to cover over-allotments, if any, at the initial public offering price less the underwriting discounts and commissions. On February 11, 2021, the underwriters fully exercised the over-allotment option.
The Company granted the underwriters a discount of $0.20 per Unit, $4,600,000 in the aggregate. An additional fee of $0.35 per Unit, or approximately $8,050,000 in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the trust account solely in the event that the company completes a Business Combination, subject to the terms of the underwriting agreement.
21
Table of Contents
Critical Accounting Policies and Estimates
The preparation of unaudited condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements, and expenses during the period reported. Actual results could materially differ from those estimates. We have identified the following critical accounting estimates effecting our unaudited condensed financial statements:
Class A Ordinary Shares Subject to Possible Redemption
We account for our Class A Ordinary Shares subject to possible redemption in accordance with the guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480. Class A Ordinary Shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. Our Class A Ordinary Shares feature certain redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future events. Accordingly, the Class A Ordinary Shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ deficit section of our condensed balance sheet.
Net Income or Loss per Share
The company complies with accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share.” Net loss per share is computed by dividing net loss by the weighted-average number of ordinary shares outstanding during the periods.
The Class B Ordinary Shares will automatically convert into Class A Ordinary Shares at the time of the company’s initial business combination on a one-for-one basis, subject to adjustment.
The company’s condensed statement of operations includes a presentation of loss per share for shares of ordinary shares subject to possible redemption in a manner similar to the two-class method of loss per share.
Adjustment associated with the redeemable Class A Ordinary Shares is excluded from loss per share as the redemption value approximates fair value.
Recent Accounting Pronouncements
Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on our unaudited condensed financial statements.
Off-balance Sheet Arrangements
As of September 30, 2022, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K.
JOBS Act
The JOBS Act contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We will qualify as an “emerging growth company” and under the JOBS Act will be allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As a result, our unaudited condensed financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.
Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an “emerging growth company,” we choose to rely on such exemptions we may not be required to, among other things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the unaudited condensed financial statements (auditor discussion and analysis) and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the principal executive officer’s compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our initial public offering or until we are no longer an “emerging growth company,” whichever is earlier.
22
Table of Contents
Item 3. | Quantitative and Qualitative Disclosures About Market Risk |
The net proceeds of the initial public offering and the sale of the private placement warrants have been and will only be invested in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. Due to the short-term nature of these investments, we believe there will be no associated material exposure to interest rate risk.
We accounted for the 23,950,000 warrants issued in connection with the initial public offering (the 11,500,000 warrants included in the units and the 12,450,000 private placement warrants) in accordance with the guidance contained in ASC 815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability. Accordingly, we classify each warrant as a liability at its fair value. This liability is subject to re-measurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in our condensed statement of operations.
Accordingly, changes in the fair value of the warrants each reporting period are adjusted through earnings, subjecting us to non-cash volatility in our results of operations.
Item 4. | Controls and Procedures |
Evaluation of Disclosure Controls and Procedures
Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.
As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2022. Based upon their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) were effective.
Changes in Internal Control over Financial Reporting
There were no changes in our internal controls over financial reporting identified in management’s evaluation pursuant to Rules 13a-15(d) or 15d-15(d) of the Exchange Act during the fiscal quarter ended September 30, 2022 covered by this Quarterly Report on Form 10-Q that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
23
Table of Contents
PART II—OTHER INFORMATION
Item 1. | Legal Proceedings |
None.
Item 1A. | Risk Factors |
As of the date of this Quarterly Report on Form 10-Q, there have been no material changes to the risk factors disclosed in the company’s Annual Report on Form 10-K filed with the SEC on September 30, 2022 except for the below risk factor. We may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.
The securities in which we invest the funds held in the trust account could bear a negative rate of interest, which could reduce the value of the assets held in trust such that the per-share redemption amount received by public shareholders may be less than $10.20 per share.
The proceeds held in the trust account will be invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act, which invest only in direct U.S. government treasury obligations. While short-term U.S. government treasury obligations currently yield a positive rate of interest, they have briefly yielded negative interest rates in recent years. Central banks in Europe and Japan pursued interest rates below zero in recent years, and the Open Market Committee of the Federal Reserve has not ruled out the possibility that it may in the future adopt similar policies in the United States. In the event that we are unable to complete our initial business combination or make certain amendments to our amended and restated memorandum and articles of association, our public shareholders are entitled to receive their pro-rata share of the proceeds held in the trust account, plus any interest income, net of income taxes paid or payable (less, in the case we are unable to complete our initial business combination, $100,000 of interest to pay dissolution expenses). Negative interest rates could reduce the value of the assets held in trust such that the per-share redemption amount received by public shareholders may be less than $10.20 per share.
Inflation Reduction Act of 2022
On August 16, 2022, the IR Act was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The Treasury has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and inhibit the Company’s ability to complete a Business Combination.
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds. |
Simultaneously with the consummation of the initial public offering on February 15, 2022, we completed the private placement of 12,450,000 private placement warrants at a purchase price of $1.00 per private placement warrant, to our sponsor, generating gross proceeds to us of $12,450,000. The private placement warrants are identical to the warrants included in the units issued in our initial public offering, except that the private placement warrants are not transferable, assignable or salable until the completion of an initial business combination, subject to certain limited exceptions. No underwriting discounts or commissions were paid with respect to such sale. The issuance of the Private Placement Warrants was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.
24
Table of Contents
In connection with the initial public offering, our sponsor had agreed to loan us an aggregate of up to $300,000 and as of December 31, 2021 we had borrowed an aggregate amount of $250,000 under an unsecured amended and restated promissory note. We fully repaid such loan upon the closing of the initial public offering
Of the gross proceeds received from the initial public offering and the full exercise of the option to purchase additional Shares, $234.6 million was placed in the trust account. The net proceeds of the initial public offering and certain proceeds from the private placement are invested in U.S. government treasury bills with a maturity of 185 days or less and in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations.
We paid a total of approximately $4,600,000 in underwriting discounts and commissions related to the initial public offering. In addition, the underwriters agreed to defer $8,050,000 in underwriting discounts and commissions.
Item 3. | Defaults upon Senior Securities |
None.
Item 4. | Mine Safety Disclosures. |
Not applicable.
Item 5. | Other Information. |
None.
Item 6. | Exhibits. |
* | These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing. |
25
Table of Contents
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: November 14, 2022 | Jaguar Global Growth Corporation I | |||||
By: | /s/ Anthony R. Page | |||||
Name: | Anthony R. Page | |||||
Title: | Chief Financial Officer |
26